His current research focuses on the identification and validation of therapeutic targets in pediatric solid tumors and rare cancers. (sciencemag.org)
Childhood Solid Tumor Network offers the world's largest and most comprehensive collection of scientific resources for studying pediatric solid tumors (stjude.org)
A phase I / II trial of nivolumab (anti-PD-1) and low dose cyclophosphamide in progressive / relapsed pediatric solid tumors -LRB- (cancerresearch.org)